Korean Market
EXCH
Samyang Biopharm
★

Samyang Biopharm Corporate Governance Report Disclosure - Newly Spin-off Entity Establishes Governance Framework but Identifies Improvement Needs in Shareholder Returns and Board Diversity

 
FTC
Samyang Biopharm
★

Samyang Biopharm Submits Annual Conglomerate Disclosure: Reveals Stable Financials and Concentrated Ownership Structure, Limited Impact on Shareholder Value

 
PERI
Samyang Biopharm
★

Samyang Biopharm Q1 2026: Revenue Growth and Net Profit Rise

 
EXCH
Samyang Biopharm
★

Notice of Regular Shareholders' Meeting - Agenda Includes Election of Audit Committee Members

 
EXCH
Samyang Biopharm
★

Introduction of Electronic Voting System - Enhancing Shareholder Convenience